Valuation: QuidelOrtho Corporation

Market Cap 946M 812M 758M 695M 1.31B 90.45B 1.33B 8.94B 3.5B 45.37B 3.55B 3.48B 150B P/E 2026 *
-3.35x
P/E 2027 * -4.96x
Enterprise Value 3.5B 3.01B 2.81B 2.58B 4.84B 335B 4.92B 33.12B 12.97B 168B 13.16B 12.87B 555B EV / Sales 2026 *
1.38x
EV / Sales 2027 * 1.33x
Free-Float
99.11%
Yield 2026 *
-
Yield 2027 * -
1 day+2.76%
1 week-6.95%
Current month-17.71%
1 month-20.60%
3 months+21.27%
6 months-41.55%
Current year-51.68%
1 week 13.2
Extreme 13.205
15.26
1 month 11.41
Extreme 11.41
18.04
Current year 9.92
Extreme 9.92
35.58
1 year 9.92
Extreme 9.92
35.58
3 years 9.92
Extreme 9.92
84.6
5 years 9.92
Extreme 9.92
180.06
10 years 9.92
Extreme 9.92
306.72
Manager TitleAgeSince
Chief Executive Officer 61 2024-05-05
Director of Finance/CFO 48 2026-07-05
Chief Operating Officer 57 2024-11-14
Director TitleAgeSince
Chairman 72 2022-12-10
Director/Board Member 71 2021-12-31
Director/Board Member 82 1992-12-31
Date Insider Type Main position Quantity % Market Cap.
7/15/26 Free

Chief Financial Officer

356,555 0.5251%
7/6/26 Other

Chief Financial Officer

0 0%
7/1/26 Fiscal year

EVP Global Port. Mgmt & Mkting

13,690 0.0202%
Change 5-day change 1-year change 3-year change Capi.($)
+2.76%-6.95%-48.40%-81.42% 946M
+3.11%-0.55%+19.14%-33.74% 17.02B
-6.49%-7.77%-43.15%+89.39% 1.61B
-0.30%-2.47%-25.08%+25.41% 978M
0.00%+0.05%+63.80%-7.38% 778M
-2.10%-3.71%-40.01%-49.41% 667M
-4.14%-7.45%-42.69%-42.07% 589M
-0.48%+7.40%-41.45%-35.58% 450M
+1.59%+2.20%+65.16%+46.08% 423M
-1.47%+2.89%-4.16%-13.18% 396M
Average -0.39%-1.50%-9.68%-10.19% 2.39B
Weighted average by Cap. +1.78%-1.43%+8.00%-22.95%

Financials

2026 *2027 *
Net sales 2.55B 2.18B 2.04B 1.87B 3.52B 243B 3.58B 24.07B 9.42B 122B 9.56B 9.35B 404B 2.59B 2.22B 2.08B 1.9B 3.58B 248B 3.64B 24.49B 9.59B 124B 9.73B 9.52B 411B
Net income -269M -231M -216M -198M -372M -25.72B -378M -2.54B -996M -12.9B -1.01B -988M -42.64B -164M -141M -131M -120M -227M -15.67B -230M -1.55B -607M -7.86B -616M -602M -25.98B
Net Debt 2.56B 2.19B 2.05B 1.88B 3.54B 245B 3.59B 24.18B 9.47B 123B 9.61B 9.4B 405B 2.49B 2.14B 2B 1.83B 3.44B 238B 3.5B 23.54B 9.22B 119B 9.35B 9.15B 395B
Logo QuidelOrtho Corporation
QuidelOrtho Corporation provides in vitro diagnostics, developing and manufacturing intelligent solutions. The Company specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. It provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics, Ortho Optix and others.
Employees
6,500
Date Price Change Volume
26-08-19 US$13.80 +2.76% 1,315,285
26-08-18 US$13.43 -7.89% 1,378,643
26-08-17 US$14.58 +1.96% 1,236,150
26-08-14 US$14.30 -5.24% 917,947
26-08-13 US$15.09 +1.75% 1,446,395
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
13.80USD
Average target price
14.67USD
Spread / Average Target
+6.28%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. QDEL Stock